Background {#Sec1}
==========

One of the most common joint problems experienced around the world is osteoarthritis \[[@CR1]\]. The prolongation of life expectancy, the increase in obesity, and the spread of immobile lifestyles are increasing the frequency of knee osteoarthritis \[[@CR2]\]. Obesity is often associated with knee osteoarthritis. This is a group of patients whom orthopaedic surgeons often encounter and treat. When a body mass index (BMI) between 25 and 29.9 is considered overweight and 30 to 34.9 is obese, it has been shown that the risk of osteoarthritis of the knee increases almost fivefold (4.78) in obese men and almost fourfold (3.87) in obese women; however, an increase of 1.69-fold in overweight men and 1.89-fold in overweight women was observed \[[@CR3]\].

Osteoarthritis usually starts from the medial compartment (80--90%) and largely remains unicompartmental \[[@CR4]\]. There are different types of surgical treatment for single-compartment osteoarthritis, including total knee arthroplasty (TKA), high tibial osteotomy (HTO) or unicompartmental knee arthroplasty (UKA). Although the prevalence of revision frequency is higher than that of TKA \[[@CR5]\] and the possibility of the opposite compartment going to arthrosis limits the preference of surgeons regarding UKA, faster recovery, less hospitalization time and reduced costs lead many surgeons to view it as an alternative surgical method instead of TKA \[[@CR5], [@CR6]\]. Fatal complications such as infections, thromboembolism and amputation are rarely seen in UKA compared to TKA \[[@CR7]\]. In addition, the minimally invasive incision reduces postoperative blood loss and pain, while better functional results, as well as rapid and early rehabilitation, are the other advantages of UKA \[[@CR5], [@CR6]\].

In recent studies, UKA has been considered the preferred replacement method over TKA and HTO in the presence of single-compartment arthrosis \[[@CR5], [@CR6]\]. In the recent past, UKA accounted for 8% of all arthroplasty practices, although this rate is steadily increasing at a rate of 30% per year in the USA \[[@CR8]\]. In some series, this rate has reached up to 50% of all replacement knees \[[@CR6]\].

In order to achieve successful outcomes, correct patient selection is one of the most important criteria following UKA. However, there are still some contraversion for indication criteria of UKA, including obesity. While BMI is a restriction in traditional indications, in recent decades, this BMI-based restriction has not been possible because of the increasing obesity pandemic that has been observed throughout the world. Although obesity is believed to reduce the functional results and implant survival in UKA \[[@CR9]--[@CR13]\], successful results have been shown for obese patients in recent studies \[[@CR14]--[@CR18]\]. The effect of BMI on functional outcomes and complication rate after UKA still remains controversial, despite the plethora of studies. Although we had a satisfactory result in obese patients in our case series, we wanted to evaluate our patients retrospectively and planned this study after having observed poor functional outcome and early failure in morbid obese patients.

The aim of this study was to evaluate and compare the functional outcomes and complication rates of patients in short-term and midterm follow-up period when medial UKA-applied patients were grouped according to BMI values.

Methods {#Sec2}
=======

After receiving ethical council approval (Reference No: 47, 07/06/2016), the medical records for all patients who underwent surgical treatment for single-compartment arthroplasty between 2011 and 2016 with a minimum 2 years follow-up were examined retrospectively. All operations were performed by a same surgeon (OG) or under his control in a single center. Application of Oxford Phase 3 medial unicompartmental cemented mobile bearing knee implants (Oxford Partial Knee, Biomet Orthopaedics, Bridgend, UK) were performed minimally invasively by the medial parapatellar approach.

Patients who had anteromedial knee arthritis except for inflammatory aetiologies were included. The inclusion criteria for UKA were determined as having an intact cruciate ligament, full-thickness lateral cartilage, flexion contracture less than 15° and fully correctable intra-articular varus deformity \[[@CR19]\]. No restrictions were applied according to bodyweight or BMI. Fifty-two patients who did not complete the 2-year follow-up period, 8 patients who lost from the postoperative follow-up, 1 patient who underwent lateral UKA and 2 patients who underwent arthrosurface hemicap procedure were excluded from this study. The remaining 104 patients were grouped according to BMI: normal and overweight group (less than 30 kg/m^2^), obese group (30--34.9 kg/m^2^) and morbidly obese group (BMI 35 and more than 35 kg/m^2^).

All patients were evaluated preoperatively with bilateral orthoroentgenograms, weight-bearing anteroposterior and flexed lateral knee X-rays and patella tangential X-rays. In addition, magnetic resonance imagining (MRI) was performed preoperatively. Postoperatively, bilateral orthoroentgenograms and weight-bearing anteroposterior and flexed lateral knee X-rays were taken.

The visual analogue scale (VAS) score, Oxford Knee Score (OKS), Knee Society Score (KSS) and functional Knee Society Score (fKSS) were used for functionally evaluating the patients, and the range of motion (ROM) was recorded for each patient pre- and postoperatively. The demographic features, functional results, preoperative and postoperative VAS and ROM and complication rate of the three subgroups of normal and overweight, obese and morbidly obese were compared. The implant positioning of the patients requiring revision was analysed according to the Oxford radiological criteria. The presence of femoral component varus or valgus of more than 10°, femoral component flexion or extension of more than 5°, tibial plateau angle varus or valgus of more than 10° and posterior tibial slope of more than 7° or less than 5° according to the normal value was evaluated as implant malposition.

In the descriptive statistics of the data, mean, standard deviation, median lowest, highest, frequency and ratio values were used. The distribution of the variables was measured with the Kolmogorov-Smirnov test. In the analysis of the quantitative independent data, the Kruskal-Wallis and Mann-Whitney *U* tests were used. The Wilcoxon signed-rank test was used for the analysis of the dependent quantitative data. The chi-square test was used for the analysis of qualitative independent data, and the Fischer test was used when the chi-square test conditions were not provided. The SPSS 22.0 programme was used in the analysis. A statistical significance level of alpha was accepted as *p* \< 0.05.

Results {#Sec3}
=======

In total, 86 patients (82.7%) were female and 18 (17.3%) were male. The mean age of the patients was 60 (range, 49--80). The left knee of 46 patients and the right knee of 58 patients underwent UKA. The mean follow-up period was 46 (range, 24--72) months. The average BMI was 34.4 (range, 22--56.9). A total of 26 (25%) of the patients were either normal weight or overweight, 40 (38.5%) were obese and 38 (36.5%) were morbidly obese. The age, gender and side distribution of the patients in the normal-overweight, obese and morbidly obese group did not differ significantly (*p* \> 0.05).

For all of these groups, the average KSS, *f* KSS and OKS improved from 43.2, 34.7 and 12.7 to 85.7, 82.0 and 37.8, respectively. Additionally, the range of knee motion improved from 111.5 to 122.8 and the average VAS score decreased from 9.0 to 2.6 (*p* \< 0.05) (Table [1](#Tab1){ref-type="table"}). Table 1All patient demographics and functional outcomeMin--MaxMedianMean ± s.d./*n*-%Age49.0--80.060.060.2 ± 7.4SexFemale86  82.7%Male18  17.3%SideRight58  55.8%Left46  44.2%Follow-up (month)24.0--72.043.546.0 ± 14.6BMI22.0--56.933.434.4 ± 6.5VASPreop6.0--10.09.01.1 ± 9.0Postop0.0--10.02.63.0 ± 2.0KSSPreop17.0--69.043.29.6 ± 44.0Postop31.0--100.085.719.8 ± 95.0fKSSPreop0.0--90.034.718.9 ± 35.0Postop0.0--100.082.024.3 ± 90.0OKSPreop0.0--32.012.77.7 ± 11.5Postop7.0--48.037.810.3 ± 41.0ROMPreop80.0--130.0111.512.4 ± 115.0Postop35.0--135.0122.816.8 ± 130.0Complication10  9.6%Revision11  10.6%

In these BMI-based groups, there were statistically significant differences according to KSS, *f* KSS, OKS and functional ROM. There was no significant difference between preoperative VAS, postoperative VAS and VAS score changes in the normal-overweight, obese and morbidly obese patients (*p* \> 0.05). There was no significant difference between preoperative KSS, *f* KSS and OKS in normal-overweight, obese and morbidly obese patients (*p* \> 0.05). Postoperative KSS, *f* KSS and OKS were significantly lower in the morbidly obese group in comparison to the normal-overweight and obese group by 75.2, 70.5 and 33.1, respectively (*p* \< 0.05). Postoperative KSS, *f* KSS and OKS changes were significantly lower in the morbidly obese group than in the normal-overweight and obese group (*p* \< 0.05). In all groups, the postoperative ROM scores increased significantly (*p* \< 0.05) compared to the preop period (*p* \< 0.05). Postoperative functional ROM scores and amount of ROM changes (4.2°) were significantly lower in the morbidly obese group compared to the normal-overweight (11.9°) and obese group (17.6°) (*p* \< 0.05) (Table [2](#Tab2){ref-type="table"}). Table 2Comparison of patient demographics, VAS, KSS, *f* KSS, OKS and ROM in BMI groupsNormal and OverweightObeseMorbidly ObeseMean ± s.d./*n*-%MedianMean ± s.d./*n*-%MedianMean ± s.d./*n*-%MedianAge61.5 ± 7.361.060.5 ± 7.760.059.0 ± 7.158.00.374^K^SexFemale2284.6%3280.0%3284.2%0.847^x2^Male415.4%820.0%615.8%SideRight1246.2%2460.0%2257.9%0.513^x2^Left1453.8%1640.0%1642.1%Follow-up42.7 ± 14.1ǂ36.040.6 ± 13.5ǂ40.053.9 ± 12.755.00.000^K^BMI27.3 ± 2.328.032.7 ± 1.533.140.9 ± 5.639.0VASPreoperative8.9 ± 0.99.09.2 ± 1.010.08.8 ± 1.29.00.232^K^Postoperative1.6 ± 1.91.02.3 ± 2.42.03.7 ± 3.82.00.099^K^Change− 7.3 ± 1.9− 7.0− 6.9 ± 2.8− 7.0− 5.2 ± 4.2− 6.00.195^K^Group exchange *p*0.000^w^0.000^w^0.000^w^KSSPreoperative44.0 ± 4.344.042.1 ± 11.843.543.9 ± 9.847.00.158^K^Postoperative96.3 ± 6.1\*ǂ100.088.8 ± 10.893.575.2 ± 27.282.00.001^K^Change52.3 ± 6.6ǂ55.046.7 ± 14.6ǂ48.531.2 ± 28.345.00.005^K^Group exchange *p*0.000^w^0.000^w^0.000^w^fKSS0.0Preoperative35.8 ± 22.250.032.3 ± 21.235.036.6 ± 13.535.00.245^K^Postoperative90.0 ± 12.6ǂ90.087.8 ± 12.4ǂ90.070.5 ± 34.080.00.013^K^Change54.2 ± 18.4ǂ50.055.5 ± 27.7ǂ60.033.9 ± 35.545.00.015^K^Group exchange *p*0.000^w^0.000^w^0.000^w^OKSPreoperative11.4 ± 7.811.011.4 ± 8.010.015.1 ± 7.016.00.071^K^Postoperative42.5 ± 4.7ǂ43.039.3 ± 7.2ǂ40.533.1 ± 13.640.00.011^K^Change31.1 ± 8.6ǂ30.027.9 ± 10.3ǂ30.018.0 ± 16.825.00.003^K^Group exchange *p*0.000^w^0.000^w^0.000^w^ROMPreoperative116.3 ± 12.0\*120.0106.9 ± 11.2110.0113.2 ± 12.5\*115.00.002^K^Postoperative128.3 ± 19.3\*ǂ130.0124.5 ± 11.8130.0117.4 ± 18.3120.00.002^K^Change11.9 ± 17.7ǂ12.517.6 ± 15.6ǂ20.04.2 ± 16.05.00.001^K^Group exchange *p*0.000^w^0.000^w^0.026^wK^ Kruskal-Wallis (Mann-Whitney *U* test)/^w^Wilcoxon test/^X2^chi-square test (Fischer test)\*Difference with the obese group *p* \< 0.05/ǂcompared with the morbid obese group *p* \< 0.05

While 100% of the normal and overweight patients reached excellent postoperative KSS, only 80% of the obese and 57.9% of the morbidly obese patients reached excellent results. Also, good and excellent functional KSS were reached by 92.3% of the normal and overweight patients, 95% of the obese patients and 73.7% of the morbidly obese patients postoperatively. Additionally, postoperative OKS were good and excellent for 100% of the normal and overweight patients, 95% of the obese patients and 68.4% of the morbidly obese patients (Table [3](#Tab3){ref-type="table"}). Table 3Postop KSS, *f* KSS and OKS result distribution of BMI groupsBMINormal-overweightObeseMorbidly obese*n*%*n*%*n*%Post KSSExcellent2610032802257.9Good00615410.5Fair002525.3Poor00001026.3Post *f* KSSExcellent2284.630752463.2Good27.7820410.5Fair27.72500Poor00001026.3Post OKSExcellent2492.33587.52257.9Good27.737.5410.5Fair0012.525.3Poor0012.51026.3

Complications developed in ten patients (9.6%). Three of the complications were intraoperative eminence fractures, two of them were insert dislocations, four of the complications were tibial component collapse and superficial infection developed in one of them, which healed with antibiotic therapy. Furthermore, six of the ten patients (60%) who developed complications were morbidly obese and four of them (40%) were obese. In this study, complications were observed in 6 (16%) of 38 morbidly obese patients and 4 (10%) of 40 obese patients. No complication was observed in 26 normal or overweight patients.

Eleven (10.6%) of the patients required revision. A total of 8 (72.7%) of these patients were morbidly obese and 3 (27.3%) of them were obese. Four morbidly obese patients underwent revision in the first 12 months. Thirty-eight (36.5%) of the total of 104 knees were in morbidly obese patients and 8 (21.1%) of these patients underwent revision. Furthermore, 5 of these 8 patients had one or more implant replacement errors and 3 of them had no implant replacement errors by the time of the UKA replacement. Three of the 8 morbidly obese patients had no other cause for revision except BMI (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, and [3](#Fig3){ref-type="fig"}). Two obese patients who needed revision also had implant replacement errors, and one of them had no implant replacement errors (Table [4](#Tab4){ref-type="table"}). Also, there is a significant difference in the mean BMI between patient groups who required surgery and those who did not. While the mean BMI of patients requiring revision was 41.7, the mean BMI for those not requiring revision was 33.5. Also, one of the morbidly obese patients who underwent revision again experienced implant loosening of TKA and revision was planned. Fig. 153-year-old 56.9 BMI patient clinical view Fig. 2Preoperative AP and lateral X-ray of the same patient Fig. 3Postoperative 12 months AP and lateral X-ray of the same patient. UKA of this patient was revised at 12 months with constraint THA Table 4Summary of revised patient findingsBMIPatient ageComp. MalpComplicationRevision reasonRevision timeRevision implant138,753PTS, TPATibial component collapseTibial loosening52 monthsConstraint TKA23365PTSEminenceTibial+femoral loosening45 monthsPrimer PCL substituting TKA341.658FCVVEminence fractureTibial loosening7 monthsPrimer PCL retaining TKA44751NoneNoneTibial+femoral loosening7 monthsPrimer PCL retaining TKA556.953NoneTibial component collapseTibial component collapse12 monthsConstraint TKA646.956PTS, TPA, FCVVInsert dislocationTibial+femoral loosening12 monthsPrimer PCL retaining TKA738.153PTS, TPANoneTibial loosening14 monthsPrimer PCL retaining TKA842.558NoneTibial component collapseTibial component collapse26 monthsPrimer PCL retaining TKA933.258FCVV, FCFENoneTibial+femoral loosening33 monthsPrimer PCL substituting TKA1046.956PTS, TPA, FCVVNoneTibial+femoral loosening16 monthsPrimer PCL substitutingTKA1134.780NoneTibial component collapseTibial+femoral loosening44 monthsConstraint TKA*PTS* posterior tibial slope, *TPA* tibia plateau angle, *FCVV* femoral component varus-valgus, *FCFE* femoral component flexion-extension, *PCL* posterior cruciate ligament

Discussion {#Sec4}
==========

The popularity of UKA has increased as excellent functional outcomes have been obtained even in long-term follow-up, and it has significant advantages compared to TKA. However, the weight or BMI of patients undergoing UKA is still controversial in the literature. In 1989, obesity was determined to be a contraindication for UKA and Kozin et al. restricted their indication criteria to 82 kg \[[@CR20]\]. While Deshmukh and Scott expanded this limit to 90 kg \[[@CR21]\], Berend and Lambordi \[[@CR19]\] did not include bodyweight in their indication criteria and Murray et al. showed that high BMI values such as 45--50 do not represent a restriction criteria in patients who undergo mobile insert UKA \[[@CR18]\]. Excess weight increases the implant interface stress and may lead to early implant loosening. Although there are many studies supporting this conviction \[[@CR9]--[@CR13]\], there are other studies claiming the opposite \[[@CR14]--[@CR18]\]. In this study, no restriction was applied according to body weight or BMI. Therefore, without making any restrictions in terms of weight, most of the patients (75%) who reached the inclusion criteria for UKA surgery were obese (38.5%) or morbidly obese (36.5%).

Component malposition is believed to increase revision rates. In such a study, femorotibial angle, tibial plateau angle, posterior tibial slope and the height of the joint line were significantly different in patients with failure after UKA \[[@CR22]\]. However, in three of eight morbidly obese patients who underwent revision surgery, component malposition was not detected in any patient according to the Oxford radiological criteria. In these three morbidly obese patients, although the component was implanted appropriately, revision was needed.

Another reason for revision knee replacement could be that the patients are younger and more active. Price et al. presented that the survival rate was 91% in patients under 60 years of age, while survival was 96% in patients over 60 years of age after 10 years of UKA \[[@CR23]\]. The mean age of the all patients was 60.2 (range, 49--80), while patients who underwent revision surgery was 58.2 (range, 51--80). This situation shows that the mean age of the patient group requiring revision is close to the mean age of the total patient group. When we refute factors such as component positioning and age, we conclude that morbid obesity is an independent risk factor for functional outcomes and implant survival after UKA.

In a large-scale study conducted with 15,770 patients who underwent UKA, the major complication rate was 3.1 times higher and the revision rate 2.1-fold higher in patients with morbid obesity compared to non-obese patients \[[@CR9]\]. Similarly, 40 patients with and without morbid obesity were treated with UKA with a minimum 2 years follow-up, and 5 revisions were needed. Five of these patients were also in the morbidly obese group \[[@CR12]\]. In this study, of the ten patients who developed complications, six were morbidly obese and four were obese. Eight of the eleven patients who underwent revision surgery were morbidly obese and three were obese.

The limitation of this study is its retrospective design; the BMI of the patients at the operation time are taken as reference, and their last follow-up BMI values are not taken into consideration. Furthermore, a larger series is needed in terms of the number of patients and follow-up time.

Conclusion {#Sec5}
==========

We recommend that morbid obesity is treated before surgical planning because it affects implant survival and functional outcomes. However, it is possible to obtain excellent results with good planning and correct surgical technique in obese and overweight patients. Morbid obese patients should be preoperatively informed about poor functional outcome and high complication rate. Treatment of morbid obesity before UKA surgery may be a good option.

BMI

:   Body mass index

fKSS

:   Functional Knee Society Scores

HTO

:   High tibial osteotomy

KSS

:   Knee Society Scores

MRI

:   Magnetic resonance imaging

OKS

:   Oxford Knee Scores

ROM

:   Range of motion

TKA

:   Total knee arthroplasty

UKA

:   Unicompartmental knee arthroplasty

VAS

:   Visual analogue scale

**Publisher's Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

We like to thank the patients who participate in this study.

AEP and BP contributed to the study design and data analysis, assisted with the operation and were major contributors in writing the manuscript. TG and EÇ contributed to the data collection and organized the operation and manuscript preparation. EÇ and OG performed surgeries, contributed to the data analysis and revised the manuscript. All authors read and approved the final manuscript.

None. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

The data of this study were real and were performed in SPSS (Version 22.0). The statistical results of the data are presented in the main paper. All of the data are available in contact with the correspondence author.

Informed consent was obtained from all the individual participants included in the study. The study was conducted according to the Helsinki Declaration (Ethical Principles for Medical Research Involving Human Subjects) and was approved by the ethics committee of Istanbul Metin Sabanci Baltalimani Bone Diseases Training and Research Hospital.

All consents to publish from the patients who took part in this study were obtained.

The authors declare that they have competing interests.
